A breast cancer patient dealing with anxiety, depression or mood swings could soon be encouraged by her oncologist to learn meditation techniques, join a yoga class or put music to therapeutic use.
Today, The American Society of Clinical Oncology (ASCO), published its endorsement of integrative therapy guidelines recently established by the Society for Integrative Oncology (SIO).
The SIO guidelines were reviewed by an ASCO expert panel co-chaired by Dr. Gary H. Lyman, an oncologist with Fred Hutchinson Cancer Research Center in Seattle, and Dr. Lorenzo Cohen of the University of Texas MD Anderson Cancer Center in Houston.
The full guidelines appear online in the Journal of Clinical Oncology.
Some of the key recommendations include:
"Patients undergoing and surviving breast cancer treatment naturally want to use every tool available to them to enhance the effectiveness of treatment and improve their quality of life," Lyman said.
"Our goal is to help cancer care specialists and their patients make appropriate individualised treatment decisions - evaluating the current medical literature on complementary therapies to determine what works, what doesn't work and what might actually be harmful instead of helpful. The guidelines should be seen only as that - guidelines - because each patient's case is unique, and there's nothing more important than the judgment of an independent, caring professional. There is a considerable lack of information on the benefits and harms of many integrative therapies in oncology and further rigorous research of such methods is greatly needed."
ASCO's expert panel said recommendations may be subject to change as additional scientific evidence is compiled, and although ASCO generally endorsed the SIO recommendations, the panel brought attention to several areas of discussion, including safety concerns about mistletoe, sometimes taken to improve quality of life, and ginseng, sometimes taken to counter fatigue.
Certain forms of ginseng could have oestrogenic properties, but more research is needed to evaluate risk in patients with oestrogen receptor-positive breast cancer.
We are an independent charity and are not backed by a large company or society. We raise every penny ourselves to improve the standards of cancer care through education. You can help us continue our work to address inequalities in cancer care by making a donation.
Any donation, however small, contributes directly towards the costs of creating and sharing free oncology education.
Together we can get better outcomes for patients by tackling global inequalities in access to the results of cancer research.
Thank you for your support.